An open label, 2-part, one-sequence, 3-period study to evaluate drug-drug interactions between DWN12088 and nebivolol or Paroxetine in healthy volunteers

Inclusion Criteria:

• Healthy male adults aged ≥ 20 and ≤ 55 years at screening
• Subjects who voluntarily decided to participate in the study and provided written consent to follow study compliance requirements after receiving a detailed explanation on this study and fully understanding the information

Exclusion Criteria:

• Subjects unable to have the standard meal provided at the study site
• Subjects who took (the day of taking the last dose) another investigational or bioequivalence study product within 180 days prior to the first dose